Eyenovia, Inc. (EYEN) financial statements (2021 and earlier)

Company profile

Business Address 295 MADISON AVENUE,
NEW YORK, NY 10017
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14205
Cash and cash equivalents14205
Prepaid expense000
Deferred costs  0
Other undisclosed current assets00(0)
Total current assets:14205
Noncurrent Assets
Property, plant and equipment000
Other undisclosed noncurrent assets000
Total noncurrent assets:000
TOTAL ASSETS:15206
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities330
Accounts payable220
Accrued liabilities000
Employee-related liabilities11 
Other undisclosed current liabilities010
Total current liabilities:331
Noncurrent Liabilities
Liabilities, other than long-term debt00 
Deferred rent credit00
Total noncurrent liabilities:00 
Total liabilities:331
Stockholders' equity
Stockholders' equity attributable to parent, including:12175
Common stock000
Additional paid in capital695324
Accumulated deficit(58)(37)(19)
Other undisclosed stockholders' equity attributable to parent  0
Total stockholders' equity:12175
TOTAL LIABILITIES AND EQUITY:15206

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Operating expenses(21)(17)(5)
Operating loss:(21)(17)(5)
Nonoperating income
(Investment Income, Nonoperating)
  0
Net loss:(21)(17)(5)
Other undisclosed net income attributable to parent00 
Net loss available to common stockholders, diluted:(21)(17)(5)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Net loss:(21)(17)(5)
Comprehensive loss, net of tax, attributable to parent:(21)(17)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: